Literature DB >> 2323772

Viral integration, fragile sites, and proto-oncogenes in human neoplasia.

N C Popescu1, D Zimonjic, J A DiPaolo.   

Abstract

To evaluate the trend of viral integration in the human genome, chromosomal localization of five DNA-containing viruses compiled from literature data was compared to the location of fragile sites and proto-oncogenes. A total of 35 regionally mapped viral integration sites from tumors and transformed cells were distributed over 19 chromosomes. Of the 35 integration sites 23 (66%) were at the bands of fragile sites, and 7 were one band away (20%). This statistically defines the correlation as highly significant (P = 0.0000183, Fisher's F-test). Five integration sites did not correspond to the location of a fragile site. Thirteen integration sites and proto-oncogenes mapped at the same bands (37%), 6 (17%) were one band apart, and at 16 integration sites (46%) no proto-oncogenes were localized (P = 0.00491). Eighteen viral integration sites, fragile sites, and proto-oncogenes (51%) were localized at the same bands or one band distant. This clustering of viral integration sites, fragile sites, and proto-oncogenes is statistically highly significant (P = 0.0000118), and indicates nonrandom viral integration in the human genome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323772     DOI: 10.1007/bf00195804

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  36 in total

1.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Authors:  T Tokino; S Fukushige; T Nakamura; T Nagaya; T Murotsu; K Shiga; N Aoki; K Matsubara
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.

Authors:  H P Wang; C E Rogler
Journal:  Cytogenet Cell Genet       Date:  1988

3.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization.

Authors:  A Mincheva; L Gissmann; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

4.  Fragile sites are targets of diverse mutagens and carcinogens.

Authors:  J J Yunis; A L Soreng; A E Bowe
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

5.  Human gene mapping 9. Paris conference (1987). Ninth International Workshop on Human Gene Mapping.

Authors: 
Journal:  Cytogenet Cell Genet       Date:  1987

6.  Consistent involvement of only 71 of the 329 chromosomal bands of the human genome in primary neoplasia-associated rearrangements.

Authors:  F Mitelman; S Heim
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

7.  Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.

Authors:  M Dürst; C M Croce; L Gissmann; E Schwarz; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Chromosomal sites of integration of simian virus 40 DNA sequences mapped by in situ hybridization in two transformed hybrid cell lines.

Authors:  M Rabin; O C Uhlenbeck; D M Steffensen; W F Mangel
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

9.  The PLC/PRF/5 human hepatoma cell line. II. Chromosomal assignment of hepatitis B virus integration sites.

Authors:  A M Bowcock; M R Pinto; E Bey; J M Kuyl; G M Dusheiko; R Bernstein
Journal:  Cancer Genet Cytogenet       Date:  1985-09

10.  A fragile site in the human U2 small nuclear RNA gene cluster is revealed by adenovirus type 12 infection.

Authors:  D M Durnam; J C Menninger; S H Chandler; P P Smith; J K McDougall
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

View more
  16 in total

1.  Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability.

Authors:  A Hellman; A Rahat; S W Scherer; A Darvasi; L C Tsui; B Kerem
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression.

Authors:  J Couturier; X Sastre-Garau; S Schneider-Maunoury; A Labib; G Orth
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site.

Authors:  D Mishmar; A Rahat; S W Scherer; G Nyakatura; B Hinzmann; Y Kohwi; Y Mandel-Gutfroind; J R Lee; B Drescher; D E Sas; H Margalit; M Platzer; A Weiss; L C Tsui; A Rosenthal; B Kerem
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

4.  Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function.

Authors:  Z Li; A Yu; A M Weiner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material.

Authors:  Alessandro Laganà; Francesco Russo; Catarina Sismeiro; Rosalba Giugno; Alfredo Pulvirenti; Alfredo Ferro
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

6.  Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma.

Authors:  M Chen; H Wang; C D Woodworth; P Lusso; Z Berneman; D Kingma; G Delgado; J A DiPaolo
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.

Authors:  Ayumi Matsuyama; Takeshi Shiraishi; Francesco Trapasso; Tamotsu Kuroki; Hansjuerg Alder; Masaki Mori; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-20       Impact factor: 11.205

8.  Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome.

Authors:  Y P Li; R Tomanin; J R Smiley; S Bacchetti
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

Review 9.  Cellular proteins involved in papillomavirus-induced transformation.

Authors:  D C Swan; S D Vernon; J P Icenogle
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 10.  Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges.

Authors:  D C Luther; Y W Lee; H Nagaraj; F Scaletti; V M Rotello
Journal:  Expert Opin Drug Deliv       Date:  2018-09-12       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.